↑Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E (Dec 1992). "The t(4;11) chromosome translocation of human acute leukemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene". Cell. 71 (4): 701–8. doi:10.1016/0092-8674(92)90603-A. PMID1423625.
↑Chen CS, Hilden JM, Frestedt J, Domer PH, Moore R, Korsmeyer SJ, Kersey JH (Sep 1993). "The chromosome 4q21 gene (AF-4/FEL) is widely expressed in normal tissues and shows breakpoint diversity in t(4;11)(q21;q23) acute leukemia". Blood. 82 (4): 1080–5. PMID8353274.
Morrissey J, Tkachuk DC, Milatovich A, et al. (1993). "A serine/proline-rich protein is fused to HRX in t(4;11) acute leukemias". Blood. 81 (5): 1124–31. PMID8443374.
Frestedt JL, Hilden JM, Kersey JH (1996). "AF4/FEL, a gene involved in infant leukemia: sequence variations, gene structure, and possible homology with a genomic sequence on 5q31". DNA Cell Biol. 15 (8): 669–78. doi:10.1089/dna.1996.15.669. PMID8769569.
Nilson I, Reichel M, Ennas MG, et al. (1997). "Exon/intron structure of the human AF-4 gene, a member of the AF-4/LAF-4/FMR-2 gene family coding for a nuclear protein with structural alterations in acute leukaemia". Br. J. Haematol. 98 (1): 157–69. doi:10.1046/j.1365-2141.1997.1522966.x. PMID9233580.
Felix CA, Kim CS, Megonigal MD, et al. (1997). "Panhandle polymerase chain reaction amplifies MLL genomic translocation breakpoint involving unknown partner gene". Blood. 90 (12): 4679–86. PMID9389682.
Isnard P, Depetris D, Mattei MG, et al. (1999). "cDNA cloning, expression and chromosomal localization of the murine AF-4 gene involved in human leukemia". Mamm. Genome. 9 (12): 1065–8. doi:10.1007/s003359900927. PMID9880680.
Felix CA, Hosler MR, Slater DJ, et al. (2000). "Duplicated regions of AF-4 intron 4 at t(4;11) translocation breakpoints". Mol. Diagn. 4 (4): 269–83. doi:10.1016/S1084-8592(99)80002-2. PMID10671636.
Reichel M, Gillert E, Breitenlohner I, et al. (2001). "Rapid isolation of chromosomal breakpoints from patients with t(4;11) acute lymphoblastic leukemia: implications for basic and clinical research". Leukemia. 15 (2): 286–8. doi:10.1038/sj.leu.2402018. PMID11236948.
Bertrand FE, Spengeman JD, Shah N, LeBien TW (2004). "B-cell development in the presence of the MLL/AF4 oncoprotein proceeds in the absence of HOX A7 and HOX A9 expression". Leukemia. 17 (12): 2454–9. doi:10.1038/sj.leu.2403178. PMID14562113.
Caslini C, Serna A, Rossi V, et al. (2004). "Modulation of cell cycle by graded expression of MLL-AF4 fusion oncoprotein". Leukemia. 18 (6): 1064–71. doi:10.1038/sj.leu.2403321. PMID14990976.
Bursen A, Moritz S, Gaussmann A, et al. (2004). "Interaction of AF4 wild-type and AF4.MLL fusion protein with SIAH proteins: indication for t(4;11) pathobiology?". Oncogene. 23 (37): 6237–49. doi:10.1038/sj.onc.1207837. PMID15221006.